Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Frampton

Showing results (81-90 of 133) with videos related to

Pageof 14
Sort By:
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists|February 24, 2021
Intersex adolescents seeking help for their depression: the case study of SPARX in New ZealandMathijs F G Lucassen, Yael Perry, Christopher Frampton, et al.
The Journal of Rheumatology|October 17, 2017
Rates of Joint Replacement Surgery in New Zealand, 1999-2015: A Comparison of Rheumatoid Arthritis and OsteoarthritisLisa K Stamp, Janine Haslett, Peter Chapman, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|July 13, 2018
A Pilot Randomized Controlled Double-Blind Trial of High- Versus Low-Dose Weekly Folic Acid in People With Rheumatoid Arthritis Receiving MethotrexateLisa K Stamp, John L OʼDonnell, Christopher Frampton, et al.
Annals of the Rheumatic Diseases|August 31, 2023
Is colchicine prophylaxis required with start-low go-slow allopurinol dose escalation in gout? A non-inferiority randomised double-blind placebo-controlled trialLisa Stamp, Anne Horne, Borislav Mihov, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|June 19, 2012
Measurement of bone density around the Oxford medial compartment knee replacement using iDXA. A precision studyNigel Gilchrist, Gary Hooper, Christopher Frampton, et al.
Australasian Journal on Ageing|September 7, 2012
Recruitment strategies for an osteoporosis clinical trial: analysis of effectivenessAllison Heard, Rachel March, Patricia Maguire, et al.
Arthritis and Rheumatism|April 11, 2012
Starting dose is a risk factor for allopurinol hypersensitivity syndrome: a proposed safe starting dose of allopurinolLisa K Stamp, William J Taylor, Peter B Jones, et al.
The Journal of Rheumatology|October 4, 2011
Effects of changing from oral to subcutaneous methotrexate on red blood cell methotrexate polyglutamate concentrations and disease activity in patients with rheumatoid arthritisLisa K Stamp, Murray L Barclay, John L O'Donnell, et al.
Drug Metabolism and Pharmacokinetics|October 3, 2018
ABCG2 rs2231142 (Q141K) and oxypurinol concentrations in people with gout receiving allopurinolLisa K Stamp, Mary Wallace, Rebecca L Roberts, et al.
Annals of the Rheumatic Diseases|August 24, 2017
Allopurinol dose escalation to achieve serum urate below 6 mg/dL: an open-label extension studyLisa K Stamp, Peter T Chapman, Murray Barclay, et al.
Pageof 14

Showing results (81-90 of 133) with videos related to

Sort By:
Pageof 14
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists|February 24, 2021
Intersex adolescents seeking help for their depression: the case study of SPARX in New ZealandMathijs F G Lucassen, Yael Perry, Christopher Frampton, et al.
The Journal of Rheumatology|October 17, 2017
Rates of Joint Replacement Surgery in New Zealand, 1999-2015: A Comparison of Rheumatoid Arthritis and OsteoarthritisLisa K Stamp, Janine Haslett, Peter Chapman, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|July 13, 2018
A Pilot Randomized Controlled Double-Blind Trial of High- Versus Low-Dose Weekly Folic Acid in People With Rheumatoid Arthritis Receiving MethotrexateLisa K Stamp, John L OʼDonnell, Christopher Frampton, et al.
Annals of the Rheumatic Diseases|August 31, 2023
Is colchicine prophylaxis required with start-low go-slow allopurinol dose escalation in gout? A non-inferiority randomised double-blind placebo-controlled trialLisa Stamp, Anne Horne, Borislav Mihov, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|June 19, 2012
Measurement of bone density around the Oxford medial compartment knee replacement using iDXA. A precision studyNigel Gilchrist, Gary Hooper, Christopher Frampton, et al.
Australasian Journal on Ageing|September 7, 2012
Recruitment strategies for an osteoporosis clinical trial: analysis of effectivenessAllison Heard, Rachel March, Patricia Maguire, et al.
Arthritis and Rheumatism|April 11, 2012
Starting dose is a risk factor for allopurinol hypersensitivity syndrome: a proposed safe starting dose of allopurinolLisa K Stamp, William J Taylor, Peter B Jones, et al.
The Journal of Rheumatology|October 4, 2011
Effects of changing from oral to subcutaneous methotrexate on red blood cell methotrexate polyglutamate concentrations and disease activity in patients with rheumatoid arthritisLisa K Stamp, Murray L Barclay, John L O'Donnell, et al.
Drug Metabolism and Pharmacokinetics|October 3, 2018
ABCG2 rs2231142 (Q141K) and oxypurinol concentrations in people with gout receiving allopurinolLisa K Stamp, Mary Wallace, Rebecca L Roberts, et al.
Annals of the Rheumatic Diseases|August 24, 2017
Allopurinol dose escalation to achieve serum urate below 6 mg/dL: an open-label extension studyLisa K Stamp, Peter T Chapman, Murray Barclay, et al.
Pageof 14